Ai T, Yang Z, Hou H, Zhan C, Chen C, Lv W, Tao Q, Sun Z, Xia L (2020) Correlation of Chest CT and RT-PCR Testing            for Coronavirus Disease 2019 (COVID-19) in China: A           Report of 1014 Cases. Radiology 296:E32-E40. doi: 10.1148/radiol.2020200642..

Amirian ES, Levy JK (2020) Current knowledge about the antivirals remdesivir (GS-5734) and GS-441524 as therapeutic options for coronaviruses. One Health 9:100128. doi:10.1016/j.onehlt.2020.100128.

Arabi YM, Shalhoub S, Mandourah Y, Al-Hameed F, Al-Omari A, Al Qasim E, Jose J, Alraddadi B, Almotairi A, Al Khatib K, Abdulmomen A, Qushmaq I, Sindi AA, Mady A, Solaiman O, Al-Raddadi R, Maghrabi K, Ragab A, Al Mekhlafi GA, Balkhy HH, Al Harthy A, Kharaba A, Gramish JA, Al-Aithan AM, Al-Dawood A, Merson L, Hayden FG, Fowler R (2015) Ribavirin and Interferon Therapy for Critically Ill Patients With Middle East Respiratory Syndrome: A Multicenter Observational Study. Clinical Infectious Diseases 70:1837-1844. doi: 10.1093/cid/ciz544.

Ayanian S, Reyes J, Lynn L, Teufel K (2020) The association between biomarkers and clinical outcomes in novel coronavirus pneumonia in a US cohort. Biomarkers in Medicine 14(22): 1091-1097. doi:10.2217/bmm-2020-0309.

Baez-Santos YM, St. John SE, Mesecar AD (2015) The SARS-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds. Antiviral Research 115:21–38. doi: 10.1016/j.antiviral.2014.12.015.

Bai Y, Yao L, Wei T, Tian F, Jin DY, Chen L, Wang M (2020) Presumed Asymptomatic Carrier Transmission of COVID-19. JAMA 323:1406-1407. doi: 10.1001/jama.2020.2565.

Baig AM, Khaleeq A, Ali U, Syeda H (2020) Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms. ACS Chemical Neuroscience 11:995-998. doi: 10.1021/acschemneuro.0c00122.

Bao L, Deng W, Gao H, Xiao C, Liu J, Xue J, Lv Q,  Liu J, Yu P, Xu Y, Qi F, Qu Y, Li F, Xiang Z, Yu H, Gong S, Liu M, Wang G, Wang S, Song Z, Zhao W, Han Y, Zhao L, Liu X, Wei Q, Qin C (2020) Reinfection could not occur in SARS-CoV-2 infected rhesus macaques. bioRxiv 2020.03.13.990226; doi: https://doi.org/10.1101/2020.03.13.990226

Barnkob MB, Pottegård A, Støvring H, Haunstrup TM, Homburg K, Larsen R, Hansen MB, Titlestad K, Aagaard B, Møller BK, Barington T (2020) Reduced prevalence of SARS-CoV-2 infection in ABO blood group O. Blood Advances 4(20): 4990–4993. doi: 10.1182/bloodadvances.2020002657.

Brigitte M, Arti B, Stephan A, Judith A, Bruno R, Christoph W (2015) MERS-COV disease associated ARDS -a case report. Critical Care Medicine 43:308.

Chan KS, Lai ST, Chu CM, Tsui E, Tam CY, Wong MM, Tse MW, Que TL, Peiris JS, Sung J, Wong VC, Yuen KY (2003) Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study. Hong Kong Medical Journal 9:399-406.

Chang D, Xu H, Rebaza A, Sharma L, Dela Cruz CS (2020) Protecting health-care workers from subclinical coronavirus infection. The Lancet Respiratory medicine 8:e13. https://doi.org/10.1016/S2213-2600(20)30066-7.

Chan-Yeung M, Xu RH (2003) SARS: epidemiology. Respirology 8:S9-S14. doi:10.1046/j.1440-1843.2003.00518.x

Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W, Li J, Zhao D, Xu D, Gong Q, Liao J, Yang H, Hou W, Zhang Y (2020a) Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. The Lancet 395:809-815. doi: 10.1016/S0140-6736(20)30360-3.

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J, Yu T, Zhang X, Zhang L (2020b) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet 395:507-513. doi: 10.1016/S0140-6736(20)30211-7.

Chen WH, Strych U, Hotez PJ, Bottazzi ME (2020c) The SARS-CoV-2 Vaccine Pipeline: an Overview. Current Tropical Medicine Reports 3:1-4. doi: 10.1007/s40475-020-00201-6.

Cheng ZJ, Shan J (2019) Novel coronavirus: where we are and what we know. Infection 48:155-163. doi: 10.1007/s15010-020-01401-y.

Chu CM, Cheng VC, Hung IF, Wong MM, Chan KH, Chan KS, Kao RY, Poon LL, Wong CL, Guan Y, Peiris JS, Yuen KY (2004) Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax 59:252-6. doi: 10.1136/thorax.2003.012658.

ClinicalTrials.gov (2020) Available at https://clinicaltrials.gov/ access on October 02, 2020.

Convalescent plasma therapy: Mayo Clinic (2020) Available at https://www.mayoclinic.org/tests-procedures/convalescent-plasma-therapy/about/pac-20486440 access on October 02, 2020.

Coronavirus Outbreak (2020) Available at https://www.worldometers.info/coronavirus/ Access on October 02, 2020

Cui J, Li F, Shi ZL (2019) Origin and evolution of pathogenic coronaviruses. Nature Reviews Microbiology 17:181–192. doi: https://doi.org/10.1038/s41579-018-0118-9.

Devaux CA, Rolain JM, Colson P, Raoult D (2020) New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?  International Journal of Antimicrobial Agents 55:105938. doi:10.1016/j.ijantimicag.2020.105938.

Dhama K, Khan S, Tiwari R, Sircar S, Bhat S, Malik YS, Singh KP, Chaicumpa W, Katterine D Bonilla-Aldana DK , Rodriguez-Morales AJ (2020a) Coronavirus Disease 2019–COVID-19. Clinical Microbiology Reviews 33 (4) e00028-20. doi: 10.1128/CMR.00028-20.

Dhama K, Patel SK, Kumar R, Rana J, Yatoo MI, Kumar A, Tiwari R, Dhama J, Natesan S, Singh R, Harapan H (2020b) Geriatric Population During the COVID-19 Pandemic: Problems, Considerations, Exigencies, and Beyond. Frontiers in Public Health 8:562. doi: 10.3389/fpubh.2020.574198. 

Dhama K, Patel SK, Pathak M, Yatoo MI, Tiwari R, Malik YS, Singh R, Sah R, Rabaan AA, Bonilla-Aldana DK, Rodriguez-Morales AJ (2020c) An update on SARS-CoV-2/COVID-19 with particular reference to its clinical pathology, pathogenesis, immunopathology and mitigation strategies. Travel Medicine and Infectious Disease 30:101755. doi: 10.1016/j.tmaid.2020.101755.

Du L, He Y, Zhou Y, Liu S, Zheng BJ, Jiang S (2009) The spike protein of SARS-CoV--a target for vaccine and therapeutic development. Nature Reviews Microbiology 7:226-36. doi: 10.1038/nrmicro2090.

Ellinghaus D, Karlsen TH (2020) Severe Covid-19 GWAS Group. Genomewide Association Study of Severe Covid-19 with Respiratory Failure. The New England Journal of Medicine 383:1522-1534. doi: 10.1056/NEJMoa2020283.

European Medicines Agency (2020) EMA Gives Advice on the Use of Non-steroidal Anti-inflammatories for COVID-19. Available from: https://www.ema.europa.eu/en/news/emagives-advice-use-non-steroidal-anti-inflammatories-covid-19. [Last accessed on 2020 Mar 25].

Florindo HF, Kleiner R, Vaskovich-Koubi D, Acúrcio RC, Carreira B, Yeini E, GaliaTiram G, Liubomirski Y, Satchi-Fainaro R (2020) Immune-mediated approaches against COVID-19. Nature Nanotechnology 15:630–645. https://doi.org/10.1038/s41565-020-0732-3.

Foy BH, Carlson JCT, Reinertsen E (2020) Association of Red Blood Cell Distribution Width With Mortality Risk in Hospitalized Adults With SARS-CoV-2 Infection. JAMA Netw Open 3(9):e2022058. doi:10.1001/jamanetworkopen.2020.22058.

Furuta Y, Komeno T, Nakamura T (2017) Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase. Proceedings of The Japan Academy Series B: Physical And Biological Sciences 93:449-463. doi:10.2183/pjab.93.027.

General Office of National Health Committee. Office of State Administration of Traditional Chinese Medicine (2020) Notice on the issuance of a programme for the diagnosis and treatment of novel coronavirus (2019-nCoV) infected pneumonia (Trial Version 4). 2020. http://bgs.satcm.gov.cn/zhengcewenjian/2020-01-28/12576.html. Accessed 29 Jan 2020.

General Office of National Health Committee. Office of State Administration of Traditional Chinese Medicine (2020) Notice on the issuance of a program for the diagnosis and treatment of novel coronavirus (2019-nCoV) infected pneumonia (Trial Version 3) (2020). Available at http://www.nhc.gov.cn/xcs/zhengcwj/202001/f492c9153ea9437bb587ce2ffcbee1fa.shtml Access on October 02, 2020.

Gerna G, Campanini G, Rovida F, Percivalle E, Sarasini A, Marchi A, Baldanti F (2006) Genetic variability of human coronavirus OC43-, 229E-, and NL63-like strains and their association with lower respiratory tract infections of hospitalized infants and immunocompromised patients. Journal of Medical Virology 78:938-49. doi: 10.1002/jmv.20645.

Graham BS (2013) Advances in antiviral vaccine development. Immunological Reviews 255:230-242. doi:10.1111/imr.12098.

Guidelines for home quarantine (2020) Available at https://www.mohfw.gov.in/pdf/Guidelinesforhomequarantine.pdf Access on October 02, 2020.

Hikmet F, Méar L, Uhlén M, Lindskog C (2020) The protein expression profile of ACE2 in human tissues. bioRxiv 2020.03.31.016048. doi: https://doi.org/10.1101/2020.03.31.016048.

Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, Müller MA, Drosten C, Pöhlmann S (2020) SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell 181:271-280.e8. doi: 10.1016/j.cell.2020.02.052.

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet 395:497-506. doi: 10.1016/S0140-6736(20)30183-5.

Jiang H, Deng H, Wang Y, Liu Z, Sun WM (2020) The possibility of using Lopinave/Litonawe (LPV/r) as treatment for novel coronavirus 2019-nCov pneumonia: a quick systematic review based on earlier coronavirus clinical studies. Zhonghua Jizhen Yixue Zazhi 29:182–6.

Jin YH, Cai L, Cheng ZS, Cheng H, Deng T, Fan YP, Fang C, Huang D, Huang LQ, Huang Q, Han Y, Hu B, Hu F, Li BH, Li YR, Liang K, Lin LK, Luo LS, Ma J, Ma LL, Peng ZY, Pan YB, Pan ZY, Ren XQ, Sun HM, Wang Y, Wang YY, Weng H, Wei CJ, Wu DF, Xia J, Xiong Y, Xu HB, Yao XM, Yuan YF, Ye TS, Zhang XC, Zhang YW, Zhang YG, Zhang HM, Zhao Y, Zhao MJ, Zi H, Zeng XT, Wang YY, Wang XH (2020) A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Military Medical Research7:4. doi: 10.1186/s40779-020-0233-6.

Kadam RU, Wilson IA (2017) Structural basis of influenza virus fusion inhibition by the antiviral drug Arbidol. Proceedings of the National Academy of Sciences of the United States of America114:206-214. doi:10.1073/pnas.1617020114.

Kampf G, Todt D, Pfaender S, Steinmann E (2020) Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. Journal of Hospital Infection 104(3):246-251. doi: 10.1016/j.jhin.2020.01.022.

Keep health workers safe to keep patients safe: Available at WHO (2020). https://www.who.int/news-room/detail/17-09-2020-keep-health-workers-safe-to-keep-patients-safe-who Access on October 02, 2020.

Khamitov RA, Loginova SI, Shchukina VN, Borisevich SV, Maksimov VA, Shuster AM (2008) Antiviral activity of arbidol and its derivatives against the pathogen of severe acute respiratory syndrome in the cell cultures. Voprosy Virusologii 53:9-13.

Khandia R, Singhal S, Kumar U, Ansari A, Tiwari R, Dhama K, Das J, Munjal A, Singh RK (2019) Analysis of Nipah Virus Codon Usage and Adaptation to Hosts. Frontiers in Microbiology 10:886. doi: 10.3389/fmicb.2019.00886.

Kim JY, Song JY, Yoon YK, Choi SH, Song YG, Kim SR, Son HJ, Jeong SY, Choi JH, Kim KM, Yoon HJ, Choi JY, Kim TH, Choi YH, Kim HB, Yoon JH, Lee J, Eom JS, Lee SO, Oh WS, Choi JH, Yoo JH, Kim WJ, Cheong HJ (2015) Middle East Respiratory Syndrome Infection Control and Prevention Guideline for Healthcare Facilities. Infection & Chemotherapy 47:278-302. doi: 10.3947/ic.2015.47.4.278.

Kruse RL (2020) Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China. F1000Research 9:72. doi: 10.12688/f1000research.22211.2. PMID: 32117569; PMCID: PMC7029759.

Kumar PA, Hu Y, Yamamoto Y, Hoe NB, Wei TS, Mu D, Sun Y, Joo LS, Dagher R, Zielonka EM, Wang de Y, Lim B, Chow VT, Crum CP, Xian W, McKeon F (2011) Distal airway stem cells yield alveoli in vitro and during lung regeneration following H1N1 influenza infection. Cell 147:525-38. doi: 10.1016/j.cell.2011.10.001.

Lagier JC, Colson P, TissotDupont H, Salomon J, Doudier B, Aubry C, Gouriet F, Baron S, Dudouet P, Flores R, Ailhaud L, Gautret P, Parola P, La Scola B, Raoult D, Brouqui P (2020) Testing the repatriated for SARS-Cov2: Should laboratory-based quarantine replace traditional quarantine?. Travel Medicine and Infectious Disease 34:101624. doi: 10.1016/j.tmaid.2020.101624.

Lai ST (2005) Treatment of severe acute respiratory syndrome. European Journal of Clinical Microbiology & Infectious Diseases 24:583-91. doi: 10.1007/s10096-005-0004-z.

Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, Azman AS, Reich NG, Lessler J (2020) The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application. Annals of Internal Medicine 172:577-582. doi: 10.7326/M20-0504.

Li G, Fan Y, Lai Y, Han T, Li Z, Zhou P, Pan P, Wang W, Hu D, Liu X, Zhang Q, Wu J (2020a) Coronavirus infections and immune responses. Journal of Medical Virology 92:424-432. doi: 10.1002/jmv.25685.

Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, Ren R, Leung KSM, Lau EHY, Wong JY, Xing X, Xiang N, Wu Y, Li C, Chen Q, Li D, Liu T, Zhao J, Liu M, Tu W, Chen C, Jin L, Yang R, Wang Q, Zhou S, Wang R, Liu H, Luo Y, Liu Y, Shao G, Li H, Tao Z, Yang Y, Deng Z, Liu B, Ma Z, Zhang Y, Shi G, Lam TTY, Wu JT, Gao GF, Cowling BJ, Yang B, Leung GM, Feng Z (2020b) Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. The New England Journal of Medicine 382:1199-1207. doi: 10.1056/NEJMoa2001316.

Lin L, Lu L, Cao W, Li T (2020) Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia. Emerging Microbes & Infections9:727-732. doi:10.1080/22221751.2020.1746199.

Lippi G, Simundic AM, Plebani M (2020) Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19). Clinical Chemistry and Laboratory Medicine 58:1070-1076. doi: 10.1515/cclm-2020-0285. PMID: 32172228.

Liu C, Zhou Q, Li Y, Garner LV, Watkins SP, Carter LJ, Smoot J, Gregg AC, Daniels AD, Jervey S, Albaiu D (2020a) Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases. ACS Central Science. 6:315-331. doi: 10.1021/acscentsci.0c00272.

Liu R, Yi S, Zhang J, Lv Z, Zhu C, Zhang Y (2020b) Viral Load Dynamics in Sputum and Nasopharyngeal Swab in Patients with COVID-19. Journal of Dental Research 99:1239-1244. doi:10.1177/0022034520946251.

Ljungström L, Pernestig AK, Jacobsson G, Andersson R, Usener B, Tilevik D (2017) Diagnostic accuracy of procalcitonin, neutrophil-lymphocyte count ratio, C-reactive protein, and lactate in patients with suspected bacterial sepsis. PLoS One 12:e0181704. doi:10.1371/journal.pone.0181704.

Mahallawi WH, Khabour OF, Zhang Q, Makhdoum HM, Suliman BA (2018) MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile. Cytokine 104:8-13. doi: 10.1016/j.cyto.2018.01.025.

Malik YS, Sircar S, Bhat S, Sharun K, Dhama K, Dadar M, Tiwari R, Chaicumpa W (2020) Emerging novel coronavirus (2019-nCoV)-current scenario, evolutionary perspective based on genome analysis and recent developments. Veterinary Quarterly 40:68-76. doi: 10.1080/01652176.2020.1727993.

Menachery VD, Schäfer A, Burnum-Johnson KE, Mitchell HD, Eisfeld AJ, Walters KB, Nicora CD, Purvine SO, Casey CP, Monroe ME, Weitz KK, Stratton KG, Webb-Robertson BM, Gralinski LE, Metz TO, Smith RD, Waters KM, Sims AC, Kawaoka Y, Baric RS (2018) MERS-CoV and H5N1 influenza virus antagonize antigen presentation by altering the epigenetic landscape. Proceedings of the National Academy of Sciences of the United States of America115:E1012-E1021. doi: 10.1073/pnas.1706928115.

Mentré F, Taburet AM, Guedj J, Anglaret X, Keïta S, de Lamballerie X, Malvy D (2015) Dose regimen of favipiravir for Ebola virus disease. The Lancet Infectious Diseases15:150-1. doi: 10.1016/S1473-3099(14)71047-3. Epub 2014 Nov 28. PMID: 25435054.

Middle East Respiratory Syndrome Coronavirus (2020) Available at: https://www.who.int/emergencies/mers-cov/en/ Access on October 02, 2020.

Ministry of AYUSH (2020) Ayurveda’s immunity boosting measures for selfcare during COVID 19 crisis. Available at https://www.mohfw.gov.in/pdf/ImmunityBoostingAYUSHAdvisory.pdf Access on October 02, 2020.

Morra ME, Van Thanh L, Kamel MG, Ghazy AA, Altibi AMA, Dat LM, Thy TNX, Vuong NL, Mostafa MR, Ahmed SI, Elabd SS, Fathima S, Le Huy Vu T, Omrani AS, Memish ZA, Hirayama K, Huy NT (1977) Clinical outcomes of current medical approaches for Middle East respiratory syndrome: A systematic review and meta-analysis. Reviews in Medical Virology 28:e1977. doi: 10.1002/rmv.1977.

Morse JS, Lalonde T, Xu S, Liu WR (2020) Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019-nCoV. Chembiochem 21:730-738. doi: 10.1002/cbic.202000047.

Mossel EC, Wang J, Jeffers S, Edeen KE, Wang S, Cosgrove GP, Funk CJ, Manzer R, Miura TA, Pearson LD, Holmes KV, Mason RJ (2007) SARS-CoV replicates in primary human alveolar type II cell cultures but not in type I-like cells. Virology 372:127-35. doi: 10.1016/j.virol.2007.09.045.

Perlman S (2020) Another decade, another coronavirus. The New England Journal of Medicine 382:760-762 https://doi.org/10.1056/NEJMe2001126.

Petitprez F, de Reyniès A, Keung EZ, Chen TW, Sun CM, Calderaro J, Jeng YM, Hsiao LP, Lacroix L, Bougoüin A, Moreira M, Lacroix G, Natario I, Adam J, Lucchesi C, Laizet YH, Toulmonde M, Burgess MA, Bolejack V, Reinke D, Wani KM, Wang WL, Lazar AJ, Roland CL, Wargo JA, Italiano A, Sautès-Fridman C, Tawbi HA, Fridman WH (2020) B cells are associated with survival and immunotherapy response in sarcoma. Nature 577:556-560. doi: 10.1038/s41586-019-1906-8.

Prentice E, Jerome WG, Yoshimori T, Mizushima N, Denison MR (2004) Coronavirus replication complex formation utilizes components of cellular autophagy. Journal of Biological Chemistry 279:10136–10141. doi: 10.1074/jbc.M306124200.

Prompetchara E, Ketloy C, Palaga T (2020) Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic. Asian Pacific Journal of Allergy and Immunology 38:1-9. doi: 10.12932/AP-200220-0772. PMID: 32105090.

Revised Discharge Policy for COVID-19: MoHFW (2020) Available at https://www.mohfw.gov.in/pdf/ReviseddischargePolicyforCOVID19.pdf Access on October 02, 2020.

Richman DD, Whitley RJ, Hayden FG (2016) Clinical virology. 4th edn. ASM Press, Washington2016.

Rockx B, Baas T, Zornetzer GA, Haagmans B, Sheahan T, Frieman M, Dyer MD, Teal TH, Proll S, van den Brand J, Baric R, Katze MG (2009) Early upregulation of acute respiratory distress syndrome-associated cytokines promotes lethal disease in an aged-mouse model of severe acute respiratory syndrome coronavirus infection. Journal of Virology 83:7062-74. doi: 10.1128/JVI.00127-09.

Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C, Zimmer T, Thiel V, Janke C, Guggemos W, Seilmaier M, Drosten C, Vollmar P, Zwirglmaier K, Zange S, Wölfel R, Hoelscher M (2020) Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany. The New England Journal of Medicine 382:970-971. doi: 10.1056/NEJMc2001468.

Russell CD, Millar JE, Baillie J (2020) Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. The Lancet 395:473-475. doi: 10.1016/S0140-6736(20)30317-2.

Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB (2020) Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review. JAMA 323:1824–1836. doi:10.1001/jama.2020.6019.

Singhal T (2020) A Review of Coronavirus Disease-2019 (COVID-19). The Indian Journal of Pediatrics 87:281-286. doi:10.1007/s12098-020-03263-6.

Sissoko D, Laouenan C, Folkesson E, M'Lebing AB, Beavogui AH, Baize S, Camara AM, Maes P, Shepherd S, Danel C, Carazo S, Conde MN, Gala JL, Colin G, Savini H, Bore JA, Le Marcis F, Koundouno FR, Petitjean F, Lamah MC, Diederich S, Tounkara A, Poelart G, Berbain E, Dindart JM, Duraffour S, Lefevre A, Leno T, Peyrouset O, Irenge L, Bangoura N, Palich R, Hinzmann J, Kraus A, Barry TS, Berette S, Bongono A, Camara MS, Chanfreau Munoz V, Doumbouya L, SouleyHarouna, Kighoma PM, Koundouno FR, RénéLolamou, Loua CM, Massala V, Moumouni K, Provost C, Samake N, Sekou C, Soumah A, Arnould I, Komano MS, Gustin L, Berutto C, Camara D, Camara FS, Colpaert J, Delamou L, Jansson L, Kourouma E, Loua M, Malme K, Manfrin E, Maomou A, Milinouno A, Ombelet S, Sidiboun AY, Verreckt I, Yombouno P, Bocquin A, Carbonnelle C, Carmoi T, Frange P, Mely S, Nguyen VK, Pannetier D, Taburet AM, Treluyer JM, Kolie J, Moh R, Gonzalez MC, Kuisma E, Liedigk B, Ngabo D, Rudolf M, Thom R, Kerber R, Gabriel M, Di Caro A, Wölfel R, Badir J, Bentahir M, Deccache Y, Dumont C, Durant JF, El Bakkouri K, GasasiraUwamahoro M, Smits B, Toufik N, Van Cauwenberghe S, Ezzedine K, D'Ortenzio E, Pizarro L, Etienne A, Guedj J, Fizet A, Barte de Sainte Fare E, Murgue B, Tran-Minh T, Rapp C, Piguet P, Poncin M, Draguez B, AllafordDuverger T, Barbe S, Baret G, Defourny I, Carroll M, Raoul H, Augier A, Eholie SP, Yazdanpanah Y, Levy-Marchal C, Antierrens A, Van Herp M, Günther S, de Lamballerie X, Keïta S, Mentre F, Anglaret X, Malvy D (2016) Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea. PLoS Medicine.13:e1001967. doi: 10.1371/journal.pmed.1001967

Stockman LJ, Bellamy R, Garner P (2006) SARS: systematic review of treatment effects. PLoS Medicine 3:e343. doi: 10.1371/journal.pmed.0030343.

Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. Geneva: World Health Organization (2004) Available at https://www.who.int/csr/sars/country/ table2004_04_21/ en/ Access on October 02, 2020.

Uluda? H, Parent K, Aliabadi HM, Haddadi A (2020) Prospects for RNAi Therapy of COVID-19. Frontiers in Bioengineering and Biotechnology 8: 916. doi:10.3389/fbioe.2020.00916. 

Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D (2020) Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell 181:281-292.e6. doi: 10.1016/j.cell.2020.02.058.

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z (2020) Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA 323:1061-1069. doi: 10.1001/jama.2020.1585.

Wang J, Nikrad MP, Phang T, Gao B, Alford T, Ito Y, Edeen K, Travanty EA, Kosmider B, Hartshorn K, Mason RJ (2011) Innate immune response to influenza A virus in differentiated human alveolar type II cells. American Journal of Respiratory Cell and Molecular Biology 45:582-91. doi: 10.1165/rcmb.2010-0108OC.

Wang Y, Lin LK (2020) An advice guideline recommended by central south hospital for the suspected patients of novel coronavirus (2019-nCoV) infected pneumonia and their close contacts as at home quarantine. 2020. Available at https://mp.weixin.qq.com/s/xFO10WAFB9OUnM7VN92R2w Access on October 02, 2020.

Weinheimer VK, Becher A, Tönnies M, Holland G, Knepper J, Bauer TT, Schneider P, Neudecker J, Rückert JC, Szymanski K, Temmesfeld-Wollbrueck B, Gruber AD, Bannert N, Suttorp N, Hippenstiel S, Wolff T, Hocke AC (2012) Influenza A viruses target type II pneumocytes in the human lung. The Journal of Infectious Diseases206:1685-94. doi: 10.1093/infdis/jis455.

WHO-China joint mission on COVID-19 final report (2020) Available at https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf Access on October 02, 2020.

Wong CK, Lam CW, Wu AK, Ip WK, Lee NL, Chan IH, Lit LC, Hui DS, Chan MH, Chung SS, Sung JJ (2004) Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clinical and Experimental Immunology 136:95-103. doi: 10.1111/j.1365-2249.2004.02415.x.

World Health Organization. Home care for patients with suspected novel coronavirus (nCoV) infection presenting with mild symptoms and management of contacts (2020) Available at https://www.who.int/publications-detail/home-care-for-patients-with-suspected-novel-coronavirus-(ncov)-infection-presenting-with-mild-symptoms-and-management-of-contacts Access on October 02, 2020.

World Health Organization. Situation reports (2020) Available at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/ Access on October 02, 2020.

Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O, Graham BS, McLellan JS (2020) Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 367:1260-1263. doi: 10.1126/science.abb2507.

Wu CJ, Huang HW, Liu CY, Hong CF, Chan Y L (2005) Inhibition of SARS-CoV replication by siRNA. Antiviral Research 65:45–48. doi: 10.1016/j.antiviral.2004.09.005.

Wu Z, McGoogan JM (2020) Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72?314 Cases From the Chinese Center for Disease Control and Prevention. JAMA 323(13):1239–1242. doi:10.1001/jama.2020.2648.

Xu XW, Wu XX, Jiang XG, Xu KJ, Ying LJ, Ma CL, Li SB, Wang HY, Zhang S, Gao HN, Sheng JF, Cai HL, Qiu YQ, Li LJ (2020a) Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series.  BMJ 368:m606. doi: 10.1136/bmj.m606.

Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, Liu S, Zhao P, Liu H, Zhu L, Tai Y, Bai C, Gao T, Song J, Xia P, Dong J, Zhao J, Wang FS (2020b) Pathological findings of COVID-19 associated with acute respiratory distress syndrome. The Lancet Respiratory Medicine 8:420-422. doi: 10.1016/S2213-2600(20)30076-X.

Zeng LK, Tao XW, YuanWH, Wang J, Liu X, Liu ZS (2020) First case of neonate infected with novel coronavirus pneumonia in China. ZhonghuaErKeZaZhi 58:E009. doi: 10.3760/cma.j.issn.0578-1310.2020.0009.

Zhang SF, Tuo JL, Huang XB, Zhu X, Zhang DM, Zhou K, Yuan L, Luo HJ, Zheng BJ, Yuen KY, Li MF, Cao KY, Xu L (2018) Epidemiology characteristics of human coronaviruses in patients
with respiratory infection symptoms and phylogenetic analysis of HCoV-OC43 during 2010-2015 in Guangzhou. PLoS One 13:e0191789. doi: 10.1371/journal.pone.0191789.

Zhao JP, Hu Y, Du RH, Chen ZS, Jin Y, Zhou M, Zhang J, Qu JM, Cao B (2020) Expert consensus on the use of corticosteroid in patients with 2019-nCoV pneumonia. ZhonghuaJie He He Hu Xi ZaZhi. 43:E007. doi: 10.3760/cma.j.issn.1001-0939.2020.0007.

Zheng HY, Zhang M, Yang CX, Zhang N, Wang XC, Yang XP, Dong XQ, Zheng YT (2020) Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients. Cellular & Molecular Immunology 17:541-543. doi: 10.1038/s41423-020-0401-3.

Zhou D, Dai SM, Tong Q (2020a) COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression. Journal of Antimicrobial Chemotherapy 75:1667-1670. doi: 10.1093/jac/dkaa114.

Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR, Zhu Y, Li B, Huang CL, Chen HD, Chen J, Luo Y, Guo H, Jiang RD, Liu MQ, Chen Y, Shen XR, Wang X, Zheng XS, Zhao K, Chen QJ, Deng F, Liu LL, Yan B, Zhan FX, Wang YY, Xiao GF, Shi ZL (2020b) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579:270-273. doi: 10.1038/s41586-020-2012-7.

Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z, Yu J, Kang M, Song Y, Xia J, Guo Q, Song T, He J, Yen HL, Peiris M, Wu J (2020) SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients. The New England Journal of Medicine 382:1177-1179. doi: 10.1056/NEJMc2001737.